ABVC BioPharma, Inc. Revenue from Contract with Customer, Including Assessed Tax
ABVC BioPharma, Inc. (ABVC) reported Revenue from Contract with Customer, Including Assessed Tax of $296.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-12
TWD
| Period end | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|
| 2015-12-31 | 50.00M TWD 10-Q · filed 2025-08-13 |
USD
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$499.95K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $296.00K 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $795.95K 10-Q/A · filed 2026-03-03 | |||
| 2024-12-31 | $296.00K 10-Q · filed 2026-08-12 | $0.00 10-K · filed 2026-03-03 | ||
| 2015-12-31 | $50.00M 10-K · filed 2025-04-15 |